Judge Issued Favorable Decision To Illumina In FTC Challenge Regarding $8B Grail Acquisition
Illumina Inc (NASDAQ:ILMN) said it received a favorable initial decision from the judge overseeing the U.S. Federal Trade Commission’s challenge to…
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
Health Canada has approved Moderna Inc's (NASDAQ:
Stryker Unveils New Gamma4 Hip Fracture Nailing System
Stryker Corporation (NYSE:SYK) has launched the Gamma4 System to provide surgeons with the next generation of Stryker’s intramedullary nailing system. The…
Nevro Wins Multiple Coverage Options For Spinal Cord Stimulation In Diabetic Neuropathy
Nevro Corp (NYSE:NVRO) announced positive updates to multiple spinal cord stimulation (SCS) coverage policies. Aetna’s new SCS policy explicitly covers PDN…
BARDA Backs Arcturus’ Influenza Vaccine Program
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) received an award for up to $63.2 million from the Biomedical Advanced Research and Development Authority…
AnaptysBio Faces Another Setback For Imsidolimab, Stalls Work In Skin Scarring Indication
AnaptysBio Inc (NASDAQ: ANAB) announced topline data from its HARP Phase 2 trial of imsidolimab for moderate-to-severe hidradenitis suppurativa (HS).
California Fast-Food Bill Faces Industry Backlash, Says Unfair To Big Chains: Report
Joe Erlinger, head of McDonald Corp’s (NYSE:MCD) the U.S. has criticized the California bill saying it unfairly targets big chains, CNBC…
Sanofi’s Rare Disease Drug Xenpozyme Scores FDA Approval
Soon after the European Commission’s (EC) approval, Sanofi SA (NASDAQ:SNY) scooped up the FDA’s OK for the first approved therapy to treat symptoms…
Despite Price Cut, RBC Capital Is Bullish On Catalent’s Long Term Targets
RBC Capital Markets cut the price target on Catalent Inc (NYSE:CTLT) from $155 to $125 with an Outperform rating. The analyst notes…